ArticleExperimental and therapeutic medicine2023

Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study.

Vasiliki Epameinondas Georgakopoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.